Vasomotor Symptoms Market
                     Vasomotor Symptoms Market Size, Epidemiology, Emerging Drugs and Key 
Players
What are Vasomotor Symptoms? 
Vasomotor  Symptoms are  one  of  the  main  symptoms  of  menopause  that  principally  include  hot
flashes and night sweats during menopause and occurs in the majority of women across the globe.
A  woman with  Vasomotor  Symptoms experiences  abundant  heat  accompanied  by  sweating  and
flushing, especially around head, neck, chest, and upper back region. This results from temperature
dysfunction that occurs due to changes in gonadal hormones.
 
 What was the market size of Hot Flashes associated with Post-Menopause in 2017?
The market size of Hot Flashes associated with Post-Menopause in the seven major market was
1,755.8 Million in 2017.
What are the Vasomotor Symptoms market drivers?
Increasing  population  of  geriatric  women,  awareness  about  women  hygiene,  changes  in  dietary
habits,  stress,  and  focus  on  hormonal  imbalance  among  women  are  the  Vasomotor  Symptoms
market drivers.
What are the Vasomotor Symptoms market barriers?
Generic  nature  of  the  market  and  Limited  understanding  of  Pathophysiology  are  the  Vasomotor
Symptoms market barriers.
Which companies are developing drugs for Vasomotor Symptoms?
KaNDy  Therapeutics,  Fervent  Pharmaceuticals,  Astellas  Pharma,  Sojournix,  Mitsubishi  Tanabe
Pharma are developing drugs for Vasomotor Symptoms treatment market.
Request for sample pages for more information on Vasomotor Symptoms forecast- 
https://www.delveinsight.com/sample-request/vasomotor-symptoms-market